###begin article-title 0
###xml 54 59 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Sialoadhesin Expressed on IFN-Induced Monocytes Binds HIV-1 and Enhances Infectivity
###end article-title 0
###begin p 1
Conceived and designed the experiments: HR CC. Performed the experiments: CC BS. Analyzed the data: HR LP CC BS. Wrote the paper: HR LP.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 145 146 145 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 185 190 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 infection dysregulates the immune system and alters gene expression in circulating monocytes. Differential gene expression analysis of CD14+ monocytes from subjects infected with HIV-1 revealed increased expression of sialoadhesin (Sn, CD169, Siglec 1), a cell adhesion molecule first described in a subset of macrophages activated in chronic inflammatory diseases.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 43 44 43 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 221 222 221 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 621 626 609 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 458 463 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 615 620 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We analyzed sialoadhesin expression on CD14+ monocytes by flow cytometry and found significantly higher expression in subjects with elevated viral loads compared to subjects with undetectable viral loads. In cultured CD14+ monocytes isolated from healthy individuals, sialoadhesin expression was induced by interferon-alpha and interferon-gamma but not tumor necrosis factor-alpha. Using a stringent binding assay, sialoadhesin-expressing monocytes adsorbed HIV-1 through interaction with the sialic acid residues on the viral envelope glycoprotein gp120. Furthermore, monocytes expressing sialoadhesin facilitated HIV-1 trans infection of permissive cells, which occurred in the absence of monocyte self-infection.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 41 42 41 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 210 211 210 211 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 77 82 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 381 386 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 474 479 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 512 517 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 631 636 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Increased sialoadhesin expression on CD14+ monocytes occurred in response to HIV-1 infection with maximum expression associated with high viral load. We show that interferons induce sialoadhesin in primary CD14+ monocytes, which is consistent with an antiviral response during viremia. Our findings suggest that circulating sialoadhesin-expressing monocytes are capable of binding HIV-1 and effectively delivering virus to target cells thereby enhancing the distribution of HIV-1. Sialoadhesin could disseminate HIV-1 to viral reservoirs during monocyte immunosurveillance or migration to sites of inflammation and then facilitate HIV-1 infection of permissive cells.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 173 176 173 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Fogg1">[1]</xref>
###xml 261 264 261 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Whitelaw1">[2]</xref>
###xml 353 356 353 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Leon1">[3]</xref>
###xml 392 395 392 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Delamarre1">[4]</xref>
###xml 477 480 477 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Trombetta1">[5]</xref>
###xml 605 608 605 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-McElrath1">[6]</xref>
###xml 646 649 646 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Sonza1">[7]</xref>
###xml 770 773 770 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-FischerSmith1">[8]</xref>
###xml 775 778 775 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Liu1">[9]</xref>
###xml 93 98 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 234 240 <span type="species:ncbi:9606">humans</span>
###xml 535 540 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 589 594 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 687 692 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 879 882 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Blood monocytes constitute an important immune cell population that is adversely impacted by HIV-1 infection. Monocytes originate in the bone marrow from myeloid precursors [1] and are released to circulation where their half-life in humans is about three days [2]. During their short life span, monocytes can differentiate to become either macrophages [3] with prolific degradative capacity [4] or dendritic cells (DCs), which effectively prime T cells by presenting antigens [5]. While macrophages and DCs are readily infected by R5 HIV-1 strains, monocytes are considered refractory to HIV-1 infection [6] with <1% of blood monocytes infected [7]. Even at this low rate of infection, HIV-1 appears to enter the central nervous system (CNS) via infiltrating monocytes [8], [9], which through the release of neurotoxins initiates the neurodegenerative processes that may end in HIV-associated dementia (HAD).
###end p 9
###begin p 10
###xml 548 552 548 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Williams1">[10]</xref>
###xml 752 756 752 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Williams1">[10]</xref>
###xml 206 211 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 306 311 <span type="species:ncbi:9606">human</span>
###xml 371 376 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 412 415 <span type="species:ncbi:11723?0.9432672590567327|species:ncbi:12845?0.02460697197539303">SIV</span>
While the frequency of HAD has decreased with prevalent use of highly active antiretroviral therapy (HAART), neurocognitive impairment remains a reality in a substantial number of individuals infected with HIV-1. A link between viral load and impaired neural function is suggested by a recent study in non-human primates indicating that monocytes may be the link between HIV-1 in the periphery and HAD. Using an SIV-infected macaque model, Williams et al., reported that neuronal injury was coincident with viremia and an activated monocyte subset [10]. By lowering the systemic viral load with antiretroviral therapy, there was a commensurate reduction in the number of infected and activated monocytes and a dramatic improvement in neuronal function [10]. These observations establish a compelling link between high viral load, activated monocytes, an increased frequency of monocyte trafficking and a direct, negative impact on neuronal function.
###end p 10
###begin p 11
###xml 125 126 125 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 394 398 394 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Pulliam1">[11]</xref>
###xml 686 690 686 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Pulliam1">[11]</xref>
###xml 754 755 754 755 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 54 59 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 168 173 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 366 371 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 458 463 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To identify cellular factors that might contribute to HIV-1 invasion of the CNS, we examined gene expression profiles of CD14+ monocytes from individuals infected with HIV-1. Using high-density cDNA microarrays, we compared gene expression profiles from subjects with high viral load (>10,000 RNA copies/ml), subjects with low viral load (<10,000 RNA copies/ml) and HIV-1 seronegative controls [11]. We observed a monocyte gene expression profile related to HIV-1 infection that indicated a "hybrid" monocyte with increased expression of macrophage-associated markers: monocyte chemotactic protein-1 (MCP-1, CCL2), CC-chemokine receptor 5 (CCR5), and sialoadhesin (Sn, CD169, Siglec 1) [11]. This was the first report of Sn expression in circulating CD14+ monocytes.
###end p 11
###begin p 12
###xml 136 140 136 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-vandenBerg1">[12]</xref>
###xml 303 307 303 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Hartnell1">[13]</xref>
###xml 410 414 410 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Kirchberger1">[14]</xref>
###xml 481 485 481 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Vanderheijden1">[15]</xref>
###xml 541 542 541 542 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 638 642 638 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-vanderKuyl1">[16]</xref>
###xml 712 716 708 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Crocker1">[17]</xref>
###xml 718 722 714 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Crocker2">[18]</xref>
###xml 843 847 839 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Munday1">[19]</xref>
###xml 911 914 907 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 419 470 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
###xml 490 493 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Sialoadhesin was first described as a lymphocyte cell adhesion molecule expressed on macrophages localized in secondary lymphoid organs [12] and later as a protein restricted to a subset of activated macrophages related to inflammatory responses associated with rheumatoid arthritis and atherosclerosis [13]. More recently, Sn has been implicated in diverse pathogenic processes including rhinovirus infection [14] and porcine reproductive and respiratory syndrome virus infection [15]. In HIV infection, Sn is induced to high levels on CD14+ monocytes shortly after infection, possibly contributing to dysregulation of the immune system [16]. Sialoadhesin preferably binds Neu5Ac in alpha2,3 glycosidic linkage [17], [18] and as the largest of the Siglecs, Sn engages sialic acid conjugates on adjacent cells mediating cell-cell interactions [19]. In contrast, shorter Siglecs bind sialic acid conjugates in a cis orientation.
###end p 12
###begin p 13
###xml 454 459 454 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 30 35 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 233 238 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 420 425 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In this study, we report that HIV-1 infection drives monocyte expression of Sn, which correlates with viral load in the periphery. We identify interferons (IFN), which have been detected in the periphery of individuals infected with HIV-1, as inducers of Sn expression in cultured monocytes. Furthermore, using a constitutive Sn-expressing cell line and IFN-stimulated primary monocytes, we describe how Sn avidly binds HIV-1 and effectively facilitates trans infection of permissive cells.
###end p 13
###begin title 14
Results
###end title 14
###begin title 15
Sialoadhesin expression correlates with viral load
###end title 15
###begin p 16
###xml 58 59 58 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 104 108 104 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Pulliam1">[11]</xref>
###xml 213 214 213 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 528 535 528 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001967-t001">Table 1</xref>
###xml 571 572 571 572 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 700 709 700 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001967-g001">Figure 1A</xref>
###xml 971 978 971 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001967-g001">Fig. 1B</xref>
###xml 1013 1020 1013 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001967-g001">Fig. 1C</xref>
###xml 98 103 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 230 235 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 271 276 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 611 616 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 795 800 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We previously reported elevated Sn gene expression on CD14+ monocytes from subjects infected with HIV-1 [11]. To determine if Sn was differentially expressed on peripheral monocytes, immunomagnetically sorted CD14+ monocytes from HIV-1 seropositive subjects (n = 24) and HIV-1 seronegative controls (n = 10) were analyzed by flow cytometry. Sialoadhesin expression, quantified as the geometric mean, along with the subject's viral load (RNA copies/ml), CD4 count (cells/ml) and therapeutic status (on or off HAART) are shown in Table 1. The range of Sn expression on CD14+ monocytes from subjects infected with HIV-1 and seronegative controls is depicted in representative frequency histogram plots (Figure 1A). To determine the relationship between Sn expression and viral load, and CD4 count, HIV-1 seropositive subjects (n = 24) were evaluated using Pearson's correlation analysis. Correlation of Sn expression was statistically significant for viral load (p<0.0017) (Fig. 1B) but not with CD4 count (p<0.08) (Fig. 1C). In a follow-up study, three seropositive subjects, initially with detectable viral loads and high Sn expression, were subsequently retested for Sn expression after successful HAART treatment suppressed viral replication to <50 copies/ml. In all three cases, Sn dropped to <200 (geometric mean) reinforcing the link between Sn expression and viral load (data not shown).
###end p 16
###begin title 17
###xml 21 22 21 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 38 41 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Sn expression on CD14+ monocytes from HIV seropositive individuals.
###end title 17
###begin p 18
###xml 73 74 73 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 421 422 421 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 465 472 465 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001967-t001">Table 1</xref>
###xml 438 441 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
(A) Representative frequency histograms of relative Sn expression on CD14+ monocytes isolated from subjects with high viral load (HVL, 214,000 RNA copies/ml, thick black line), low viral load (LVL, 6,350 RNA copies/ml, thin black line) and a seronegative control (dotted line). The isotype-matched control mAb is shown in the shaded profile. (B) Correlation analysis of Sn expression and viral load. Sn expression on CD14+ monocytes from HIV seropositive subjects (Table 1, n = 24) was determined by flow cytometry and quantified as a geometric mean for each subject. Pearson's correlation analysis showed statistical significance between Sn expression and the log of the subject's viral load (p<0.0017). (C) Correlation analysis of Sn expression and CD4 (counts/ml) revealed no significant relationship (p<0.08).
###end p 18
###begin title 19
###xml 57 62 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Clinical data and Sn expression levels from controls and HIV-1 seropositive subjects.
###end title 19
###begin p 20
###xml 31 36 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Data for controls (C, n = 10), HIV-1 seropositive subjects (V, n = 24)
###end p 20
###begin p 21
Data sorted on increasing viral load
###end p 21
###begin p 22
Sialoadhesin (Sn) expression on CD14+ monocytes by flow cytometry quantified as the geometric mean
###end p 22
###begin p 23
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HIV RNA copies/ml
###end p 23
###begin p 24
CD4 positive cells/ml
###end p 24
###begin p 25
On (+) or off (-) highly active antiretroviral therapy; Structured treatment interruption (STI)
###end p 25
###begin title 26
###xml 33 41 33 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Interferons induce Sn expression in vitro
###end title 26
###begin p 27
###xml 174 178 174 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Hartnell1">[13]</xref>
###xml 341 345 333 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Hartnell1">[13]</xref>
###xml 501 505 493 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Tilton1">[20]</xref>
###xml 607 608 587 588 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 708 709 688 689 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 914 920 882 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001967-g002">Fig. 2</xref>
###xml 1132 1138 1088 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001967-g002">Fig. 2</xref>
###xml 1293 1298 1249 1254 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
###xml 223 228 <span type="species:ncbi:9606">human</span>
###xml 385 390 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 624 629 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1176 1181 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1288 1291 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1482 1487 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We wanted to know what soluble factors might drive monocyte Sn expression in the periphery. In mice, Sn expression is associated with inflammation in a subset of macrophages [13]; an analogous Sn response was elicited from human monocyte-derived macrophages when treated with a combination of tumor necrosis factor (TNF)-alpha and IFN-gamma [13]. However, in individuals infected with HIV-1, viremia coincided with induction of type I IFN-stimulated gene transcripts and not proinflammatory cytokines [20]. We investigated if TNF-alpha, IFN-gamma or IFN-alpha, would effectively induce Sn expression on CD14+ monocytes from HIV-1 seronegative subjects. To prevent attachment activation, freshly isolated CD14+ monocytes were cultured in low-adherent well plates and assayed for Sn expression by flow cytometry within 48 h. We found that Sn expression was induced by both IFN-alpha and IFN-gamma but not TNF-alpha (Fig. 2). When analyzed for their effect on THP-1 cells, a monocytic cell line, IFN-alpha, IFN-gamma and TNF-alpha all induced Sn expression indicating that Sn is differentially controlled in monocytes and THP-1 cells (Fig. 2). We also tested the hypothesis that HIV-1 might directly induce Sn expression on monocytes. When either PBMC or monocytes were treated with 5 ng/ml HIV-1NL4-3, flow cytometry analysis 48 h later did not detect an increase in Sn expression (data not shown). While not definitive, our data suggests that Sn expression in subjects infected with HIV-1 is orchestrated by IFN, which is an innate immune response to viremia.
###end p 27
###begin title 28
###xml 56 57 48 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Interferon-alpha and -gamma induce Sn expression on CD14+ monocytes and THP-1 cells.
###end title 28
###begin p 29
Cells were cultured in 500 U/ml IFN-alpha, 100 U/ml IFN-gamma or 10 ng/ml TNF-alpha at 37degreesC for 48 h and analyzed for Sn expression by flow cytometry. Sn expression on IFN-alpha-, IFN -gamma- or TNF-alpha-treated cells (thick black lines) and untreated cells (thin black line) were relative to an isotype-matched mAb control (shaded region). Results shown are representative histograms from three independent experiments using monocytes from three seronegative donors.
###end p 29
###begin title 30
Sn expression in a transduced THP-1 cell line
###end title 30
###begin p 31
###xml 201 209 201 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SIGLEC 1</italic>
###xml 339 347 339 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SIGLEC 1</italic>
###xml 672 680 672 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SIGLEC 1</italic>
###xml 1020 1029 1020 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001967-g003">Figure 3A</xref>
###xml 1051 1060 1051 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001967-g003">Figure 3B</xref>
###xml 66 71 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 730 733 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Sialoadhesin was cloned by PCR from monocyte RNA obtained from an HIV-1 seropositive individual with a high viral load. The cloned structural gene (5130 base pairs) was sequenced and compared with the SIGLEC 1 in the National Center for Biotechnology Information (NCBI) database (accession number NM_023068). Sequence data from the cloned SIGLEC 1 consistent with the NCBI sequence with the exception of two single nucleotide polymorphisms (dbSNP: 6037651 and dbSNP: 709012) in the cloned gene, which generated two sense mutations outside the sialic acid-binding domain. Neither polymorphism is known to influence the expression or alter the function of Sn. Subsequently, SIGLEC 1 was subcloned into an expression cassette with a CMV promoter for constitutive expression and then packaged into a lentiviral vector to transduce monocytic THP-1 cells. An Sn-expressing cell line, TSn, was generated by clonal expansion of a single transductant. Analyses of the TSn cell line showed the 190 kDa Sn protein by Western blot (Figure 3A) and flow cytometry (Figure 3B).
###end p 31
###begin title 32
Constitutive Sn expression in THP-1 by gene transduction (TSn).
###end title 32
###begin p 33
###xml 166 169 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
(A) Immunoblot analysis of Sn protein expression. THP-1 cell line was transduced with a plasmid encoding Sn cloned downstream of the high-level constitutive promoter CMV. Cell lysates were standardized, reduced with DTT and 10 microg of protein were loaded into each well: monocytes (lane 1), IFN-alpha-induced monocytes (lane2), THP-1 (lane 3) and TSn (lane 4) (M, molecular size marker). (B) Histogram of relative distribution of Sn on the cell surface of TSn clone. TSn (thick black line) and THP-1 cells (thin black line) were evaluated for Sn expression by flow cytometry using anti-Sn mAb 7D2 relative to the background isotype-matched control mAb (shaded region).
###end p 33
###begin title 34
###xml 24 29 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Sn-dependent binding of HIV-1
###end title 34
###begin p 35
###xml 214 215 214 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 259 264 259 264 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 485 490 479 484 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 492 499 486 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001967-g004">Fig. 4A</xref>
###xml 619 623 613 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Hartnell1">[13]</xref>
###xml 740 745 734 739 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 906 915 900 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001967-g004">Figure 4A</xref>
###xml 1101 1106 1095 1100 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 1136 1141 1130 1135 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 1223 1232 1217 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001967-g004">Figure 4A</xref>
###xml 1288 1293 1282 1287 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 1315 1320 1309 1314 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 1407 1412 1401 1406 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 1514 1521 1508 1515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001967-g003">Fig. 3A</xref>
###xml 1562 1567 1556 1561 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 135 140 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 254 257 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 480 483 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 526 531 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 735 738 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 799 802 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 943 946 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 980 983 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1058 1063 <span type="species:ncbi:9606">human</span>
###xml 1096 1099 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1131 1134 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1283 1286 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1310 1313 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1402 1405 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1557 1560 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Since Sn is capable of binding sialic acid conjugates on adjoining cells, we considered the possibility that Sn would effectively bind HIV-1 via the sialic acid residues on gp120. In binding assays, TSn cells (1x106 cells/ml) were incubated with 8 ng/ml HIV-1NL4-3 for 1 h at 37degreesC. After extensive washing to remove nonspecifically bound virus, TSn cells were lysed and assayed for p24 by ELISA. When compared to THP-1 controls, TSn cells bound approximately four-fold more HIV-1NL4-3 (Fig. 4A). To characterize the TSn-HIV-1 interaction, TSn cells were preincubated with an anti-Sn monoclonal antibody (mAb) 7D2 [13], which recognizes the V-set, N-terminal sialic acid binding region of Sn. Preincubation with mAb 7D2 abrogated HIV-1NL4-3 binding to TSn demonstrating that Sn is required for HIV binding. As a control, pretreatment with a IgG1 isotype antibody did not interfere with virus binding (Figure 4A). To determine whether the HIV receptor CD4 was contributing to HIV binding in this assay, THP-1 and TSn cells were preincubated with an anti-human CD4 mAb prior to challenge with HIV-1NL4-3. There was no change in HIV-1NL4-3 binding for either THP-1 or TSn respectively, compared to the untreated control (Figure 4A). With solid evidence that Sn was responsible for HIV-1NL4-3 binding to TSn, HIV-1NL4-3 was pretreated with sialidase to remove terminal sialic acids. Sialidase-treated HIV-1NL4-3 resulted in significantly reduced binding to TSn cells but had no appreciable effect on THP-1 cells (Fig. 3A). These findings demonstrated that HIV-1NL4-3 binding to TSn is dependent on a viral sialic acid ligand and cellular expressed Sn.
###end p 35
###begin title 36
###xml 15 23 15 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 9 14 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Sn binds HIV-1 in vitro.
###end title 36
###begin p 37
###xml 98 103 98 103 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 529 530 519 520 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 627 628 617 618 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 14 19 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 93 96 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 108 113 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 216 221 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 236 241 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 333 338 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 546 551 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 579 584 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 787 792 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(A) TSn binds HIV-1 in an Sn-dependant manner. TSn and THP-1 were incubated with lab-adapted HIV-1NL4-3, an HIV-1 clade B primary isolate or clade C primary isolate for 1 h at 37degreesC, washed and then assayed for HIV-1 p24 by ELISA. HIV-1 binding to Sn was abrogated by pretreatment of cells with Sn mAb 7D2 or by pretreatment of HIV-1 with broad-spectrum sialidase. Pretreatment with IgG1 isotype control or CD4 mAbs did not reduce binding. Data presented are the average of 3 separate experiments. (B) IFN-alpha-treated CD14+ monocytes bind HIV-1 in an Sn-dependant manner. HIV-1 binding assays were also performed on CD14+ monocytes from seronegative controls treated with 500 U/ml IFN-alpha to induce Sn expression. Pretreatment with Sn mAb 7D2 and sialidase dramatically reduced HIV-1 binding while pretreatment with IgG1 isotype control or CD4 mAbs had little effect. Data represents monocytes from four separate donors. Error bars represent SD.
###end p 37
###begin p 38
###xml 353 358 353 358 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 467 474 467 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001967-g004">Fig. 4A</xref>
###xml 45 48 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 176 181 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 348 351 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
During infection, the hyper-mutation rate of HIV generates significant genetic variation in circulating virus. To analyze whether genetic diversity might impact virus binding, HIV-1 primary isolates from clade B and clade C were evaluated for their ability to bind Sn. Results showed that primary isolates bound to TSn cells in a manner similar to HIV-1NL4-3 and that binding was abrogated by pretreatment with the anti-Sn mAb 7D2 or virus pretreated with sialidase (Fig. 4A).
###end p 38
###begin p 39
###xml 123 124 123 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 248 253 240 245 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 339 346 331 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001967-g004">Fig. 4B</xref>
###xml 403 408 395 400 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 542 547 526 531 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 587 592 571 576 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 684 691 668 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001967-g004">Fig. 4B</xref>
###xml 50 55 <span type="species:ncbi:9606">human</span>
###xml 74 79 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 140 143 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 243 246 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 398 401 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 537 540 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 582 585 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Next, we examined the capacity of Sn expressed on human monocytes to bind HIV-1. Sn expression was induced by treating CD14+ monocytes from HIV seronegative controls with 500 U/ml IFN-alpha for 48 h. IFN-alpha-induced monocytes incubated with HIV-1NL4-3 bound approximately three-fold more virus compared to non-induced monocyte controls (Fig. 4B). Preincubation with mAb 7D2 significantly reduced HIV-1NL4-3 binding to IFN-alpha-treated monocytes comparable to that observed for non-induced monocytes, indicating that IFN-alpha-induced HIV-1NL4-3 binding was due to Sn alone. When HIV-1NL4-3 was pretreated with sialidase, subsequent binding to Sn-expressing monocytes was impaired (Fig. 4B). Additional binding assays using primary isolates with IFN-alpha-treated monocytes demonstrated that Sn bound primary isolates with equal effectiveness. As before, virus adsorption could be prevented to a significant extent by pretreatments with anti-Sn mAb 7D2 or sialidase.
###end p 39
###begin title 40
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
Sn facilitates trans infectivity
###end title 40
###begin p 41
###xml 175 180 175 180 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 262 266 262 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Wei1">[21]</xref>
###xml 311 316 311 316 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 443 448 443 448 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 657 664 657 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001967-g005">Fig. 5A</xref>
###xml 716 721 716 721 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 804 809 804 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 828 833 828 833 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 850 855 850 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 975 980 975 980 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 1020 1025 1020 1025 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 1180 1187 1180 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001967-g005">Fig. 5A</xref>
###xml 34 39 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 170 173 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 306 309 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 438 441 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 711 714 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 823 826 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 970 973 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1015 1018 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Having shown that Sn avidly binds HIV-1, we explored the possibility that this might impact virus infectivity. To test this theory, we employed an infectious lab-adapted HIV-1NL4-3 strain and a reporter cell line TZM-bl, which expresses luciferase when infected [21]. TZM-bl cells, which are permissive to HIV-1NL4-3 infection, express the viral receptor CD4 and coreceptors CCR5 and CXCR4. When THP-1 cells were pulsed with concentrated HIV-1NL4-3 stock for 1 h, washed extensively to remove nonspecifically bound virus and cocultured for 48 h with adherent TZM-bl cells, luciferase activity was slightly above background at 55 relative light units (RLU) (Fig. 5A). In contrast, TZM-bl cells cocultivated with HIV-1NL4-3-pulsed TSn cells, expressed high levels of luciferase (897 RLU) indicating robust trans infection by HIV-1NL4-3. To verify that trans infection was dependent on Sn binding of viral sialic acid conjugates, TSn was preincubated with mAb 7D2 prior to HIV-1NL4-3 exposure. Consistent with the Sn- HIV-1NL4-3 binding assay, pre-treatment of TSn with mAb 7D2 reduced infection in the reporter cells as illustrated by the dramatic reduction in luciferase activity (Fig. 5A).
###end p 41
###begin title 42
###xml 13 18 13 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
Sn-dependent trans infection of reporter cells TZM-bl.
###end title 42
###begin p 43
###xml 100 105 96 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 138 143 134 139 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 402 407 398 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 516 521 512 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 574 579 570 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 782 787 778 783 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 67 72 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 133 136 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 208 213 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 484 489 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 777 780 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
(A) Sn-expressing cells, TSn and IFN-alpha-induced monocytes, bind HIV-1 and infect TZM-bl cells in trans. Cells were incubated with HIV-1NL4-3 for 1 h, washed and then cocultured with TZM-bl cells for 48 h. HIV-1 infection of TZM-bl was defined by luciferase expression and quantified as relative light units (RLU). Cells pretreated with Sn mAb 7D2 showed significantly reduced capacity to facilitate trans infection of TZM-bl cells while mAb IgG1 isotype control had no effect. (B) HIV-1 receptor inhibitors block trans infection. Receptor and coreceptor requirements for trans infection of TZM-bl cells were tested by incubating TZM-bl cells with receptor inhibitors including mAbs to CD4, CXCR4 or CCR5, and small molecules AMD3100 or TAK779 prior to adding TSn with bound HIV-1NL4-3. The CD4, CXCR4, CCR5, AMD3100 and TAK779 receptor inhibitors were tested individually with TZM-bl and did not induce luciferase expression (data not shown). As a control, productive infection of TSn cells was prevented by addition of indinavir (100 microM). Data presented are the average of three separate experiments. Error bars represent SD.
###end p 43
###begin p 44
###xml 42 43 42 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 68 73 68 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 280 285 276 281 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 440 445 436 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 457 464 453 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001967-g005">Fig. 5A</xref>
###xml 539 545 535 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001967-g002">Fig. 2</xref>
###xml 32 37 <span type="species:ncbi:9606">human</span>
###xml 128 133 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 242 247 <span type="species:ncbi:9606">human</span>
###xml 275 278 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 395 400 <span type="species:ncbi:9606">human</span>
###xml 796 801 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We then tested the potential of human CD14+ monocytes to facilitate trans infection of TZM-bl cells by isolating monocytes from HIV-1 seronegative subjects and inducing Sn expression with a 48 h pre-treatment of IFN-alpha. When Sn-expressing human monocytes were pulsed with HIV-1NL4-3 and subsequently cocultured with TZM-bl cells, luciferase activity exceeded 625 RLU indicating Sn-expressing human monocytes were capable of facilitating trans infection (Fig. 5A). By comparison, non-induced monocytes, which have minimal Sn expression (Fig. 2), exhibited low luciferase activity. As a control, IFN-alpha treatment of TZM-bl cells resulted in luciferase activity equal to that of background (data not shown). These results suggest that peripheral monocytes expressing Sn are capable of binding HIV-1 and presenting infectious virus to susceptible cells.
###end p 44
###begin p 45
###xml 37 42 37 42 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 80 85 80 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 144 149 144 149 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 532 537 528 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 565 570 561 566 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 604 611 600 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001967-g005">Fig. 5B</xref>
###xml 32 35 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 139 142 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 560 563 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
It was imperative that Sn-bound HIV-1NL4-3 be the only source of virus in these trans infection assays. We considered the possibility that HIV-1NL4-3-infected TSn cells would provide a secondary source of virus. To block any potential release of infectious virus from TSn cells during the 48 h culture period, assays were performed using indinavir (100 microM), a protease inhibitor. When indinavir was added to the cultures, there was no decrease in luciferase activity effectively demonstrating that TZM-bl cells were infected by trans infection of Sn-bound HIV-1NL4-3 and not from infected TSn cells (Fig. 5B).
###end p 45
###begin p 46
###xml 27 32 27 32 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 185 190 185 190 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 420 424 420 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Wang1">[22]</xref>
###xml 444 449 444 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 548 555 548 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001967-g005">Fig. 5B</xref>
###xml 622 626 622 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Hendrix1">[23]</xref>
###xml 653 657 653 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Endres1">[24]</xref>
###xml 673 678 673 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 710 717 710 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001967-g005">Fig. 5B</xref>
###xml 786 791 786 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Wu1">[25]]</xref>
###xml 803 808 803 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Baba1">[26]]</xref>
###xml 842 847 842 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 869 874 869 874 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 1033 1038 1033 1038 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 22 25 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 180 183 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 302 305 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 864 867 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1028 1031 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The fact the Sn binds HIV-1NL4-3 and facilitates trans infection raised the possibility that normal receptor CD4 and chemokine coreceptor requirements might be altered by Sn-bound HIV-1NL4-3. We tested this possibility by treating TZM-bl cells with blocking antibodies and small molecules that prevent HIV infection by binding to CD4 and coreceptors CXCR4 and CCR5. Pretreatment of the TZM-bl cells with anti-CD4 mAb B4 [22] reduced subsequent trans infection to background levels indicating that CD4 remains essential for infection in this model (Fig. 5B). Blocking coreceptor CXCR4 with either a small molecule, AMD3100 [23] or an anti-CXCR4 mAb 12G5 [24] also abrogated trans infection of the TZM-bl cells (Fig. 5B). Also, two inhibitors of the CCR5 coreceptor, an anti-CCR5 mAb 2D7 [25]] and TAK779 [26]], which should not interfere with trans infection since HIV-1NL4-3 uses the CXCR4 coreceptor, had no effect. From these data we conclude that Sn does not bypass receptor and coreceptor requirements for the T-tropic (X4) HIV-1NL4-3 strain.
###end p 46
###begin title 47
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 infectivity enhanced by Sn
###end title 47
###begin p 48
###xml 185 190 185 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 281 286 281 286 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 609 615 609 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001967-g006">Fig. 6</xref>
###xml 862 868 862 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001967-g006">Fig. 6</xref>
###xml 903 908 903 908 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 73 78 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 276 279 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 898 901 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1187 1190 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Since individuals with detectable viral loads have circulating cell-free HIV-1, we examined the capacity of Sn-expressing cells to adsorb cell-free virus in conditioned medium and then trans infect reporter cells. In a capture assay, TZM-bl cell cultures were inoculated with HIV-1NL4-3 followed by subsequent addition of either TSn or THP-1 cells. The baseline value for infectivity was established with cell-free virus in the absence of any monocytic cells. After a 48 h incubation, increasing concentrations of cell-free virus correlated with luciferase expression and therefore infection of TZM-bl cells (Fig. 6). Addition of THP-1 cells had minimal impact on TZM-bl infection and was comparable to cell-free virus. However, when TSn cells were added, infectivity of the reporter cells increased dramatically as demonstrated by elevated luciferase activity (Fig. 6). In fact, over the range of HIV-1NL4-3 concentrations from 800 pg/ml to 8000 pg/ml, virus infectivity was enhanced over 5-fold in the presence of Sn compared to cell-free virus. These data indicate that Sn captures cell-free virus and increases the rate of infection suggesting that Sn may function as an enhancer of HIV infection in the periphery.
###end p 48
###begin title 49
###xml 33 38 33 38 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 28 31 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Sn-expressing cells capture HIV-1NL4-3 and enhance infectivity.
###end title 49
###begin p 50
###xml 69 74 69 74 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 201 206 201 206 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 238 243 238 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 343 348 343 348 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 64 67 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 196 199 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 338 341 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
TZM-bl cell cultures were seeded with various concentrations of HIV-1NL4-3 (800-8000 pg/ml). Monocytic cells, TSn or THP-1 cells, were added and cocultured for 48 h. The capacity of Sn to capture HIV-1NL4-3 in the cell culture medium and trans infect TZM-bl cells was analyzed for TSn, THP-1 and cell-free virus. Luciferase expression in HIV-1NL4-3-infected TZM-bl cells was quantified as relative light units (RLU). Results were compiled from 3 separate experiments. Error bars represent SD.
###end p 50
###begin title 51
Discussion
###end title 51
###begin p 52
###xml 441 445 441 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Pulliam1">[11]</xref>
###xml 763 771 763 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1099 1103 1087 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Sinicco1">[27]</xref>
###xml 1196 1200 1180 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Stylianou1">[28]</xref>
###xml 1202 1206 1186 1190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-vonSydow1">[29]</xref>
###xml 1284 1288 1268 1272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-FitzgeraldBocarsly1">[30]</xref>
###xml 1290 1294 1274 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Schmidt1">[31]</xref>
###xml 1519 1523 1496 1500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Tilton1">[20]</xref>
###xml 1707 1711 1680 1684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Tilton1">[20]</xref>
###xml 1986 1990 1959 1963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-vanderKuyl1">[16]</xref>
###xml 2336 2340 2309 2313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Hartnell1">[13]</xref>
###xml 205 210 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 847 852 <span type="species:ncbi:9606">human</span>
###xml 954 959 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1190 1195 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1422 1425 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1913 1918 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1954 1962 <span type="species:ncbi:9606">patients</span>
###xml 2094 2102 <span type="species:ncbi:9606">patients</span>
Myeloid lineage cells including monocytes, macrophages and dendritic cells, tightly regulate Sn expression in response to specific disease conditions. Presently, the specific factor(s) elevating Sn during HIV-1 infection are not known. We show that Sn expression correlates with viral loads that range from undetectable (<50 copies/ml) to unsuppressed (>800,000 RNA copies/ml). This finding was consistent with our previous microarray study [11] which suggested that viral load was a determining factor in Sn expression. This interpretation was further supported by data from subjects whose viral loads, initially high, were suppressed to undetectable levels following HAART treatment and exhibited a concurrent decrease in Sn expression. In combination with our in vitro data showing that IFN-alpha and IFN-gamma induce Sn expression in cultured human monocytes and THP-1 cells, it is possible that either of these cytokines drives Sn expression during HIV-1 infection. IFN-gamma, which is associated with immune activation, is produced by T cells and NK cells during the acute period of infection [27]. By comparison, IFN-alpha, which is present in the serum of individuals infected with HIV-1 [28], [29], is released by plasmacytoid dendritic cells in an innate antiviral response [30], [31]. In a study by Tilton et al., monocyte production of proinflammatory cytokines, IL-1beta, IL-6 and TNF-alpha was diminished in HIV viremia suggesting that monocyte function was impaired during unsuppressed viral replication [20]. Coincident with the loss of monocyte function was an increase in Sn expression. Importantly, this particular phenotype could be recapitulated by stimulating monocytes with IFN-alpha [20]. Further substantiating the link between Sn expression and viral load was an observation in a treatment naive population that Sn mRNA expression in CD14+ monocytes dramatically increased shortly after HIV-1 infection and continued to rise in patients who progressed to AIDS [16]. Since high viral load is a common feature of AIDS, elevated Sn expression would be predicted in these patients. In aggregate, our data suggest that elevated Sn expression on monocytes is consistent with an antiviral response, as opposed to a restricted marker of inflammation observed in tissue macrophages associated with rheumatoid arthritis [13]. While our findings indicate that either IFN-alpha or IFN-gamma could induce Sn expression in peripheral monocytes, determining the specific conditions and cytokines responsible for Sn induction will require additional research.
###end p 52
###begin p 53
###xml 105 110 105 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 168 173 168 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 381 386 381 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 466 470 466 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Saphire1">[32]</xref>
###xml 472 476 472 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Bobardt1">[33]</xref>
###xml 533 536 533 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 639 643 639 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-fudeParseval1">[34]</xref>
###xml 645 650 645 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trans</italic>
###xml 827 831 827 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Mellman1">[35]</xref>
###xml 1111 1116 1111 1116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 1231 1235 1231 1235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Geijtenbeek1">[36]</xref>
###xml 1504 1508 1504 1508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Kwon1">[37]</xref>
###xml 1596 1601 1596 1601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 1657 1660 1657 1660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 1723 1727 1723 1727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Burleigh1">[38]</xref>
###xml 1800 1805 1800 1805 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 1957 1962 1957 1962 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 1973 1977 1973 1977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Boggiano1">[39]</xref>
###xml 2046 2051 2046 2051 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 2116 2121 2116 2121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 2289 2294 2289 2294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 2406 2411 2406 2411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 83 88 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 151 156 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 546 551 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1027 1032 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1403 1408 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2188 2191 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Our findings present the first characterization of a monocyte protein that adsorbs HIV-1 and facilitates trans infection. A similar capability to bind HIV-1 and effect trans infection has been described for other proteins including syndecan and DC-SIGN. Syndecan, a cell surface heparan sulfate proteoglycan expressed on macrophages, endothelial cells and fibroblasts, facilitates trans infection of T cells and can preserve virus infectivity for an extended period [32], [33]. When expressed on macrophages, syndecan functions as a cis-oriented HIV-1 receptor with the virus exploiting similar attachment motifs on both syndecan and CCR5 [34]. Trans infection has also been demonstrated in DCs, which scavenge and internalize pathogens in tissues and then migrate to lymph nodes where they present antigens to resting T cells [35]. A subset of DCs express DC-SIGN (dendritic cell - specific intercellular adhesion molecule-grabbing nonintegrin), a type II transmembrane protein with a C-type lectin ectodomain that can adsorb HIV-1 but does not serve as receptor for viral fusion. Initially, DC-SIGN-dependent trans infection of permissive cells was shown to occur in the absence of infection or even internalization of the virus [36]. However, recent reports present alternative pathways by which DC-SIGN may support infection of permissive cells. DC-SIGN has been shown to rapidly internalize intact HIV-1 into non-degradative compartments where the virus remains competent to infect permissive cells [37]. Moreover, it has been shown that DC-SIGN-mediated internalization is not required for trans-enhancement but instead DC-SIGN facilitates productive cis-infection of immature DCs and subsequent infection of T cells [38]. Also it has been reported that DC-SIGN is not required for DC-mediated trans infection based on observations that neither down-regulating DC-SIGN expression nor binding of an anti-DC-SIGN antibody adversely impacted DC-mediated trans infection [39]. By comparison, our experiments conclusively show that Sn-dependent trans infection is not due to productive infection of TSn cells since trans infection assays were done in the presence of indinavir, a potent HIV protease inhibitor. Furthermore, our results are consistent with Sn being solely responsible for trans infection since the anti-Sn mAb 7D2, which recognizes the Sn sialic acid binding region, effectively abrogates trans infection of the reporter cells.
###end p 53
###begin p 54
###xml 411 415 411 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-vandenBerg1">[12]</xref>
###xml 435 439 435 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-vandenBerg2">[40]</xref>
###xml 1011 1015 1011 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001967-Sun1">[41]</xref>
###xml 186 191 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 483 488 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 568 573 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 959 964 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1158 1163 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1226 1231 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A possible mechanism that would explain Sn-enhanced infectivity would be that by binding both virus and target cells, Sn effectively increases the localized virus concentration bringing HIV-1 in close proximity to CD4 and chemokine coreceptors on the target cell. Early characterization of Sn expressed on macrophages identified it as a lymphocyte adhesion molecule that binds sialic acid conjugates on T cells [12], specifically CD43 [40]. Having clearly demonstrated that Sn binds HIV-1, Sn could possibly perform dual functions, with some Sn protein capturing free HIV-1 while other Sn molecules would engage sialic acid conjugates on the target cell. This interaction would overcome the electrostatic repulsive forces created by net negative charges on the virus and the target cell surface. Repulsive forces modulate virus-cell interactions as demonstrated by treating primary mononuclear cells with purified sialidase, which increased susceptibility to HIV-1 infection by reducing electrostatic repulsion [41]. The hypothesis is that desialylation enhances the interaction of viral gp120 and cell associated CD4/chemokine coreceptors thereby promoting HIV-1-mediated syncytium formation. These observations suggest that HIV-1 can exploit either condition: When sialic acid conjugates are intact, Sn binds the virus and subsequently delivers the virus to permissive cells. Or, if sialic acids are cleaved from gp120 by endogenous sialidase activity, the electrostatic repulsion is reduced permitting viral interaction with the cellular CD4/chemokine coreceptors.
###end p 54
###begin p 55
###xml 140 145 140 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 23 28 <span type="species:ncbi:9606">human</span>
###xml 115 120 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 358 363 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In this study, we used human monocytes and a stably transduced cell line to demonstrate the capacity of Sn to bind HIV-1 and facilitate the trans infection of permissive cells. While the biological relevance of Sn expression on circulating monocytes remains to be determined, the potential impact of enhancing viral infectivity and possibility disseminating HIV-1 via monocyte trafficking to the CNS are clearly important considerations.
###end p 55
###begin title 56
Materials and Methods
###end title 56
###begin title 57
Cells and viruses
###end title 57
###begin p 58
###xml 14 22 14 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 224 226 224 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 233 235 233 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 646 651 636 641 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 884 889 874 879 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 1026 1034 1016 1024 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 54 59 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 641 644 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 717 722 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 742 747 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 879 882 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 911 916 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1035 1040 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Monocytes for in vitro experiments were isolated from HIV-1 seronegative healthy donors (Blood Centers of the Pacific, San Francisco, CA). In brief, cells were flushed out of leuko-reduction filters with 40 ml PBS without Ca2+ and Mg2+ using a syringe. Monocytes were enriched by negative selection using RosetteSep according to the manufacturer (StemCell Technologies, Vancouver, BC), with >80% purity by flow cytometry. THP-1 cells were obtained from the Cell Culture Facility (UCSF, San Francisco, CA) and cultured in RPMI-1640 supplemented with 10% FBS, 1.0 microg/ml gentamicin and 2 mM L-glutamine at 37degreesC in 5% CO2. Lab-adapted HIV-1NL4-3 was a generous gift from Dr. Joe Wong. Primary isolates 92US660 (HIV-1 B1) and MW/93/959 (HIV-1 C2) and reporter cell line TZM-bl were obtained from NIH AIDS Research and Reference Reagent Program (Germantown, MD). Lab-adapted HIV-1NL4-3 and primary isolates HIV-1 B1 and C2 were replicated in PBMC from 3 seronegative donors (Blood Centers of the Pacific) using a standard in vitro HIV-1 replication protocol (SRA Life Sciences; available on the NIH AIDS Research and Reference Reagent Program website). TZM-bl cells were also obtained from the NIH AIDS Research and Reference Reagent Program and cultured in DMEM H-21 supplemented with 10% FBS and 1.0 microg/ml gentamicin at 37degreesC in 5% CO2.
###end p 58
###begin title 59
###xml 18 25 18 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Quantification of in vivo Sn expression by flow cytometry
###end title 59
###begin p 60
###xml 233 234 233 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1065 1066 1065 1066 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 823 828 <span type="species:ncbi:9606">human</span>
###xml 919 924 <span type="species:ncbi:10090">mouse</span>
###xml 947 952 <span type="species:ncbi:10090">Mouse</span>
This study received IRB approval from the University of California, San Francisco and the Veterans Affairs Medical Center, San Francisco and written consent was obtained from participating subjects. For flow cytometric analysis, CD14+ monocytes were isolated within 2 h from fresh blood obtained from donors recruited at the San Francisco VA Medical Center. In brief, 30 ml of blood was collected in BD Vacutainer CPT tubes (BD, Franklin Lakes, NJ) and centrifuged to enrich for PBMC. Monocytes were isolated from PBMC by positive immunomagnetic cell sorting using CD14 Microbeads (Miltenyi Biotec, Auburn, CA) which yielded >90% purity when assayed by flow cytometry (FACSCalibur; BD Biosciences, San Jose, CA) using anti-CD14-FITC (BD Pharmingen, San Diego, CA). Sn expression was quantified by flow cytometry using anti-human Sn monoclonal antibody (mAb) 7D2 (Novus Biologicals, Littleton, CO) and secondary PE anti-mouse IgG1 (BD Pharmingen). Mouse IgG1 (BD Pharmingen) was used as a non-specific control antibody. The geometric mean of the channel value for 104 cells was determined using CellQuest software (BD Biosciences).
###end p 60
###begin title 61
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
In vitro induction of Sn
###end title 61
###begin p 62
###xml 19 20 19 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 69 70 69 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 347 348 325 326 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 36 41 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
THP-1 cells or CD14+ monocytes from HIV-1 seronegative controls (1x106 cells) were stimulated with 500 U/ml IFN-alpha2a (PBL Biomedical Laboratories, Piscataway, NJ), 100 U/ml IFN-gamma or 10 ng/ml TNF-alpha (R&D Systems, Minneapolis, MN) in RPMI-1640 supplemented with 10% FBS, 1.0 microg/ml gentamicin and 2 mM L-glutamine at 37degreesC in 5% CO2 for 48 h in Costar Ultra Low Attachment plates (Corning, Lowell, MA) with rotation to prevent adherence.
###end p 62
###begin title 63
SN cloning and constitutive expression in clone TSn
###end title 63
###begin p 64
###xml 33 34 33 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 532 581 502 551 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- TGA TAT CTT AAG GCA CAA GAA CCT GCT ATG G -3&#8242;</named-content>
###xml 594 640 564 610 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- AGA TAT CTA GAC AAC ACC ACT GGT CAG CC -3&#8242;</named-content>
###xml 1025 1026 993 994 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 1294 1295 1248 1249 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 62 67 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Total RNA was extracted from CD14+ monocytes isolated from an HIV-1 seropositive individual using RNeasy Mini kit (Qiagen, Valencia, CA). cDNA was generated using Superscript III First-strand cDNA Synthesis kit (Invitrogen, Carlsbad, CA). SN was cloned by RT-PCR (94degreesC for 2 min followed by 35 cycles of 94degreesC for 30 sec, 58degreesC for 1 min, 72degreesC for 6 min with extension at 72degreesC for 10 min) using FailSafe PCR PreMix Selection Kit (Epicentre Biotechnologies, Madison, WI). Primers were as follows: forward 5'- TGA TAT CTT AAG GCA CAA GAA CCT GCT ATG G -3' and reverse 5'- AGA TAT CTA GAC AAC ACC ACT GGT CAG CC -3'. The PCR product was inserted into pCR2.1 and sequenced (Cleveland Genomics, Cleveland, OH). SN was cloned into pENTR1A then subcloned into pLenti6/V5-Dest using Gateway(R) technology and then packaged into the lentiviral vector using ViraPower Lentiviral Expression System in a 293FT cell line (all from Invitrogen). Lentiviral suspensions (3 ml) were combined with THP-1 cells (1x107) and mixed with polybrene (8 microg/ml). Lentivirus was loaded onto THP-1 cells by spinoculation (600xg for 1.5 h). After, cells were resuspended in RPMI-1640 supplemented with 10% FBS, 1.0 microg/ml gentamicin and 2 mM L-glutamine and cultured at 37degreesC in 5% CO2. Clonal selection was done in the presence of 5 microg/ml blasticidin.
###end p 64
###begin title 65
Immunoblot
###end title 65
###begin p 66
###xml 78 79 74 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 708 713 <span type="species:ncbi:9796">horse</span>
###xml 719 724 <span type="species:ncbi:10090">mouse</span>
THP-1, TSn, monocytes and monocytes stimulated with 500 U/ml IFN-alpha2a (2x106) were washed with PBS and lysed with ice-cold lysis buffer containing 10 mM HEPES pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 0.5 mM PMSF, 1 mM DTT and 0.5% NP-40. Cell lysates were normalized by protein concentration, reduced with DTT and 10 microg of sample protein were loaded into a 4-12% Bis-Tris gel (Invitrogen). Proteins were fractionated in reducing conditions by electrophoresis for 1 h at 200 V, electroblotted for 1 h at 100 V onto a polyvinylidene difluoride (PVDF) membrane (GE Healthcare, Picastaway, NJ). The PVDF membrane was probed with Sn mAb 7D2 (1:1000; Novus Biologicals) and secondary peroxidase-labeled horse anti-mouse IgG (1:5000; Vector Laboratories, Burlingame, CA) then visualized with ECL plus on a Typhoon Scanner (GE Healthcare, Picastaway, NJ).
###end p 66
###begin title 67
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 9 12 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
In vitro HIV binding assays
###end title 67
###begin p 68
###xml 37 42 37 42 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 207 208 203 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 692 694 664 666 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 715 738 687 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Clostridium perfringens</italic>
###xml 32 35 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 73 78 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 432 437 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 664 669 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 715 738 <span type="species:ncbi:1502">Clostridium perfringens</span>
###xml 788 793 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 827 830 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Cellular binding of lab-adapted HIV-1NL4-3 and primary isolates clade B (HIV-1 92US660) and clade C (MW/93/959) was assessed using THP-1, TSn, monocytes and IFN-alpha2a-stimulated monocytes. In brief, 2.5x105 cells/250 microl PBS were pulsed with 2 ng p24-normalized virus stocks for 1 h at 37degreesC. Cells were vigorously washed 5 times with PBS by vortexing and centrifugation at 300xg. To demonstrate that increased binding of HIV-1 to TSn and monocytes stimulated with IFN-alpha2a involved Sn, cells were pretreated with 0.5 microg Sn mAb 7D2, mAb IgG1 isotype control (Novus) or CD4 mAb RPA-T4 (BD Bioscience) for 1 h at 37degreesC. Sialic acid residues on HIV-1 were removed with 4x10-4 U/ml sialidase from Clostridium perfringens (Roche, Indianapolis, IN) for 1 h at 37degreesC. HIV-1 bound to cells was quantified by HIV p24 ELISA (Zeptometrix, Buffalo, NY).
###end p 68
###begin title 69
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trans</italic>
Trans infection assay
###end title 69
###begin p 70
###xml 55 56 55 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 178 179 168 169 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 202 203 192 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 324 325 304 305 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 449 450 425 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 500 505 472 477 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 859 864 815 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 1185 1186 1125 1126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 1238 1239 1172 1173 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 495 498 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
TZM-bl cells were distributed into 96-well plates (5x103 cells/well) and cultured in RPMI-1640 supplemented with 10% FBS, 1.0 microg/ml gentamicin for 48 h at 37degreesC in 5% CO2. On the same day, CD14+ monocytes from controls were isolated and half were stimulated with 500 U/ml IFN-alpha2a for 48 h at 37degreesC in 5% CO2 with rotation to prevent adherence to plastic. After, THP-1, TSn, monocytes and monocytes stimulated with IFN-alpha2a (1x106 cells/250 microl PBS) were pulsed with 2 ng HIV-1NL4-3 for 1 h at 37degreesC, washed vigorously 5 times with PBS by vortexing and centrifugation at 300xg, then resuspended in 1 ml RPMI-1640+10% FBS. To demonstrate involvement of Sn, cells were pretreated with 0.5 microg Sn mAb 7D2 or mAb IgG1 isotype control for 1 h at 37degreesC and washed 3 times with PBS. To confirm which coreceptors were required for trans infection via TSn, TZM-bl cells were pretreated with 0.5 microg/ml anti-CD4 RPA-T4 (BD Bioscience), 0.5 microg/ml anti-CXCR4 12G5 or anti-CCR5 2D7, or 10 microM AMD3100 or TAK779 (all from NIH AIDS Research and Reference Reagent Program). After, the TZM-bl media was replaced with 100 microl of the cell suspension (1x105 cells) and cultured for 48 h at 37degreesC in 5% CO2. Productive infection of TSn and TZM-bl cells was prevented by the presence of 100 microM indinavir protease inhibitor (NIH AIDS Research and Reference Reagent Program). Infection of the TZM-bl cells was quantified as relative light units (RLU) produced by luciferase expression using the Bright-Glotrade mark detection system (Promega, Madison, WI) and a SpectraMax M5 microplate reader (Molecular Devices, Sunnyvale, CA).
###end p 70
###begin title 71
###xml 20 25 20 25 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 15 18 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Enhancement of HIV-1NL4-3 infectivity
###end title 71
###begin p 72
###xml 51 56 51 56 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 97 105 97 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in trans</italic>
###xml 157 158 157 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 253 254 247 248 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 322 327 312 317 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</sub>
###xml 349 350 335 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 46 49 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 317 320 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The ability of Sn-expressing cells to capture HIV-1NL4-3 in solution and then infect TZM-bl cell in trans was compared to cell-free virus. TZM-bl cells (5x103 cells/well) were distributed into 96-well plates and incubated for 48 h at 37degreesC in 5% CO2. After, the media was replaced with 50 microl of dilutions of HIV-1NL4-3 and 50 microl of 2x105 THP-1 or TSn cells. The plate was rotated at 1000 rpm for 1 min and incubated for 48 h at 37degreesC. Luciferase activity was measured using the Bright-Glotrade mark(Promega) and a SpectraMax M5 microplate reader (Molecular Devices).
###end p 72
###begin p 73
We thank Sandy Charles R.N. and Harry Lampiris M.D. for recruiting subjects participating in this study and Joe Wong M.D. for viral isolates. We acknowledge the NIH AIDS Research and Reference Reagents Program for providing reagents used in this research.
###end p 73
###begin title 74
References
###end title 74
###begin article-title 75
A clonogenic bone marrow progenitor specific for macrophages and dendritic cells.
###end article-title 75
###begin article-title 76
###xml 16 21 <span type="species:ncbi:9606">human</span>
Observations on human monocyte kinetics after pulse labeling.
###end article-title 76
###begin article-title 77
Monocyte-derived dendritic cells.
###end article-title 77
###begin article-title 78
Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate.
###end article-title 78
###begin article-title 79
Activation of lysosomal function during dendritic cell maturation.
###end article-title 79
###begin article-title 80
###xml 7 12 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 96 104 <span type="species:ncbi:9606">patients</span>
Latent HIV-1 infection in enriched populations of blood monocytes and T cells from seropositive patients.
###end article-title 80
###begin article-title 81
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes.
###end article-title 81
###begin article-title 82
###xml 66 69 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 123 126 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection.
###end article-title 82
###begin article-title 83
###xml 12 47 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 71 78 <span type="species:ncbi:9606">patient</span>
###xml 84 87 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Analysis of human immunodeficiency virus type 1 gp160 sequences from a patient with HIV dementia: evidence for monocyte trafficking into brain.
###end article-title 83
###begin article-title 84
###xml 98 101 <span type="species:ncbi:11723?0.9432672590567327|species:ncbi:12845?0.02460697197539303">SIV</span>
Magnetic resonance spectroscopy reveals that activated monocytes contribute to neuronal injury in SIV neuroAIDS.
###end article-title 84
###begin article-title 85
###xml 71 76 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Invasive chronic inflammatory monocyte phenotype in subjects with high HIV-1 viral load.
###end article-title 85
###begin article-title 86
Sialoadhesin on macrophages: its identification as a lymphocyte adhesion molecule.
###end article-title 86
###begin article-title 87
###xml 20 25 <span type="species:ncbi:9606">human</span>
Characterization of human sialoadhesin, a sialic acid binding receptor expressed by resident and inflammatory macrophage populations.
###end article-title 87
###begin article-title 88
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human rhinoviruses inhibit the accessory function of dendritic cells by inducing sialoadhesin and B7-H1 expression.
###end article-title 88
###begin article-title 89
###xml 40 91 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
Involvement of sialoadhesin in entry of porcine reproductive and respiratory syndrome virus into porcine alveolar macrophages.
###end article-title 89
###begin article-title 90
###xml 74 79 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Sialoadhesin (CD169) Expression in CD14+ Cells Is Upregulated Early after HIV-1 Infection and Increases during Disease Progression.
###end article-title 90
###begin article-title 91
Siglecs: a family of sialic-acid binding lectins.
###end article-title 91
###begin article-title 92
###xml 79 85 <span type="species:ncbi:10090">murine</span>
Purification and properties of sialoadhesin, a sialic acid-binding receptor of murine tissue macrophages.
###end article-title 92
###begin article-title 93
Sialic acid binding receptors (siglecs) expressed by macrophages.
###end article-title 93
###begin article-title 94
###xml 67 95 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Diminished production of monocyte proinflammatory cytokines during human immunodeficiency virus viremia is mediated by type I interferons.
###end article-title 94
###begin article-title 95
###xml 23 58 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 62 70 <span type="species:ncbi:9606">patients</span>
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.
###end article-title 95
###begin article-title 96
###xml 69 72 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Postexposure immunoprophylaxis of primary isolates by an antibody to HIV receptor complex.
###end article-title 96
###begin article-title 97
###xml 97 102 <span type="species:ncbi:9606">human</span>
Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers.
###end article-title 97
###begin article-title 98
###xml 29 34 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
CD4-independent infection by HIV-2 is mediated by fusin/CXCR4.
###end article-title 98
###begin article-title 99
###xml 85 90 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro.
###end article-title 99
###begin article-title 100
###xml 83 88 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity.
###end article-title 100
###begin article-title 101
###xml 35 40 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Cytokine network and acute primary HIV-1 infection.
###end article-title 101
###begin article-title 102
###xml 155 158 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Interferons and interferon (IFN)-inducible protein 10 during highly active anti-retroviral therapy (HAART)-possible immunosuppressive role of IFN-alpha in HIV infection.
###end article-title 102
###begin article-title 103
###xml 61 69 <span type="species:ncbi:9606">patients</span>
###xml 91 96 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Interferon-alpha and tumor necrosis factor-alpha in serum of patients in various stages of HIV-1 infection.
###end article-title 103
###begin article-title 104
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human natural interferon-alpha producing cells.
###end article-title 104
###begin article-title 105
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HIV-infected cells are major inducers of plasmacytoid dendritic cell interferon production, maturation, and migration.
###end article-title 105
###begin article-title 106
###xml 44 79 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages.
###end article-title 106
###begin article-title 107
###xml 43 46 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Syndecan captures, protects, and transmits HIV to T lymphocytes.
###end article-title 107
###begin article-title 108
###xml 45 50 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A highly conserved arginine in gp120 governs HIV-1 binding to both syndecans and CCR5 via sulfated motifs.
###end article-title 108
###begin article-title 109
Dendritic cells: specialized and regulated antigen processing machines.
###end article-title 109
###begin article-title 110
###xml 35 40 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells.
###end article-title 110
###begin article-title 111
###xml 36 39 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection.
###end article-title 111
###begin article-title 112
###xml 76 104 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells.
###end article-title 112
###begin article-title 113
###xml 45 80 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Dendritic cell-mediated trans-enhancement of human immunodeficiency virus type 1 infectivity is independent of DC-SIGN.
###end article-title 113
###begin article-title 114
Cutting edge: CD43 functions as a T cell counterreceptor for the macrophage adhesion receptor sialoadhesin (Siglec-1).
###end article-title 114
###begin article-title 115
###xml 52 57 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Neuraminidase from a bacterial source enhances both HIV-1-mediated syncytium formation and the virus binding/entry process.
###end article-title 115
###begin p 116
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 116
###begin p 117
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This research was supported by grants from the National Institutes of Health (NIMH) R01MH073478 (LP) and a University of California, Universitywide AIDS Research Program (UARP) grant ID06-NCIRE-245 (LP).
###end p 117

